Myasthenia gravis (MG) is the most extensively studied antibody-mediated disease in
humans. Substantial progress has been made in the treatment of MG in the last century …

Therapies for myasthenia gravis (MG) include symptomatic and immunosuppressive/
immunomodulatory treatment. Options for immunosuppression include corticosteroids …

Therapeutic plasma exchange (TPE) has been mainly used in the treatment of autoimmune
diseases. The main mechanisms of action of TPE include the removal of circulating …

Therapies for myasthenia gravis (MG) include symptomatic and immunosuppressive
treatment. Options for immunosuppression include corticosteroids, azathioprine …

Introduction: Plasma exchange (PLEX) is effective in myasthenia gravis (MG), but there are
concerns about its safety. Methods: We collected data prospectively from 42 patients …

Abstract Neonatal Fc receptor (FcRn) blockade may represent a mechanism similar to
plasma exchange (PLEX) in reducing immunoglobulin levels and thus have a broad …

The prevalence of myasthenia gravis (MG), an autoimmune disorder, is increasing among
all subsets of the population leading to an elevated economic and social burden. The …

With the exception of thymectomy, immune modulatory treatment strategies and clinical trials
in myasthenia gravis over the past 50 y were mainly borrowed from experience in other …

Hypertriglyceridemia (hyperTG) is a common form of dyslipidemia and is frequently
associated with premature coronary disease, and when severe, recurrent events of …

Myasthenia gravis (MG) is a chronic neuromuscular disease characterized by muscular
weakness and fatigability. Dental management of patients diagnosed with MG presents a …